Key result
Losartan attenuated hypercholesterolemia-induced cardiac, hepatic, and renal toxicities in rats by down-regulating oxidative damage, inflammation, and necrosis.
Why the study?
This study explored the protective role of losartan against oxidative and inflammatory damage in heart, liver, and kidney tissues in hypercholesterolemic rats.
Does losartan reduce oxidative and inflammatory injuries in hypercholesterolemic rats?
Does losartan reduce oxidative and inflammatory injuries in hypercholesterolemic rats?
Losartan demonstrates protective effects against hypercholesterolemia-induced oxidative, inflammatory, and structural damage in cardiac, hepatic, and renal tissues in a rat model.
Answers are grounded in this paper and cite their sources.
Supports losartan testing in hypercholesterolemia models; leaves open translation to human therapy.
Objectives: This study explores the protective role of losartan (LT) against oxidative and inflammatory damages in different physiological systems including heart, liver, and kidney tissue in hypercholesterolemic rats.Methods: After induction of hypercholesterolemia by high cholesterol diet for 6 weeks, LT was administered for 4 weeks. In serum, the levels of lipoproteins, aminotransferases, creatine kinases, urea, apoptosis, and inflammatory markers were measured. In cardiac, hepatic, and renal tissues, lipid peroxidation product and GSH as well as antioxidant enzymatic activities were assayed. Finally, histopathological assessment evaluated the structural damage in cardiac, hepatic, and renal tissues.Results: Serum markers of cardiac, hepatic, and renal toxicities including creatine kinases, aminotransferases, and urea were attenuated by LT in hypercholesterolemic animals. Moreover, LT markedly corrected the elevated levels of lipoproteins, apoptosis, and inflammatory biomarkers. Hypercholesterolemia-induced lipid peroxidation, low GSH levels, and diminished activities of antioxidant enzymes were prominently improved in LT treated animals. Histopathological alterations by hypercholesterolemia in heart, liver, and kidney tissues were ameliorated by LT.Conclusion: This study confirmed the pathological enrollment of renin–angiotensin system in hypercholesterolemia-associated metabolic alterations. LT had a significant cardiac, hepatic, and renal protective role against these impairments through down-regulation of oxidative damage, inflammation and necrosis.
No takes yet. Share an insight, caveat, or question.
Alsaad et al. (2020) studied Hypercholesterolemia. Losartan was evaluated on Serum markers of cardiac, hepatic, and renal toxicities, lipoproteins, apoptosis, inflammatory biomarkers, and tissue oxidative stress. Losartan attenuated hypercholesterolemia-induced cardiac, hepatic, and renal toxicities in rats by down-regulating oxidative damage, inflammation, and necrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: